(Bloomberg) -- The US Department of Justice sued top health insurance companies and brokers alleging they used illegal kickbacks to steer members into certain private Medicare Advantage plans. Most Read from Bloomberg NJ Transit Urges Commuters to Work Remotely If Union Strikes NYC Lost $9 Billion of Income to Miami, Palm Beach in Five Years New York City Transit System Chips Away at Subway Fare Evasion NYC’s Congestion Toll Raised $159 Million in the First Quarter The Last Thing US Transit Agencies Should Do Now The complaint names units of CVS Health Corp., Elevance Health Inc. and Humana Inc., along with broker companies eHealth, Inc., GoHealth, Inc., and SelectQuote Inc. The government lawsuit, which was initiated by a whistleblower in 2021 and unsealed Thursday, alleges that brokers told their agents to sell Medicare Advantage based on the kickbacks and blocked the sale of insurance plans that didn’t pay. The complaint, which covers behavior from 2016 through 2021, further alleges that Aetna and Humana pressured brokers to enroll fewer disabled people in their plans. Medicare Advantage is a private version of Medicare, the government health plan mostly for people in the US aged 65 and older. Over half of the Medicare population are enrolled in these private plans. They often enroll in plans with the help of a broker, who may be paid commissions by insurance companies. Congress has investigated these payments before. EHealth, GoHealth, and SelectQuote previously disclosed that they received subpoenas from the US Attorney’s Office in Massachusetts in 2022 regarding their arrangements with insurers. That office is one of several involved in the lawsuit unsealed Thursday. “We are still reviewing the complaint, but disagree with the allegations, and intend to defend the case vigorously,” CVS spokesperson David Whitrap said. Shares of all the insurers and broker companies fell after the news was announced. Representatives from Elevance and Humana did not respond to requests for comment. Emails to eHealth, GoHealth, and SelectQuote were not immediately returned. (Updates throughout.) Most Read from Bloomberg Businessweek Made-in-USA Wheelbarrows Promoted by Trump Are Now Made in China As More Women Lift Weights, Gyms Might Never Be the Same Can the Labubu Doll Craze Survive Trump’s Tariffs? The Mastermind of the Yellowstone Universe Isn’t Done Yet Healthy Sodas Like Poppi, Olipop Are Drawing PepsiCo’s and Coca-Cola’s Attention ©2025 Bloomberg L.P. View Comments
US Alleges Medicare Insurers, Brokers Used Illegal Kickbacks
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...